Cibus director buys 666,666 shares at $1.50
Cibus, Inc. director Jean-Pierre Jules Lehmann reported buying 666,666 shares of Class A common stock at $1.50 per share in an underwritten public offering that closed on January 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cibus, Inc. director Jean-Pierre Jules Lehmann reported buying 666,666 shares of Class A common stock at $1.50 per share in an underwritten public offering that closed on January 30, 2026. After the purchase, he directly owned 699,156 shares and was deemed to beneficially own an additional 1,687,071 shares held by JPL Investments, SA. The transaction was approved by Cibus, Inc.’s board of directors under Rule 16b-3.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 666,666 | $1.50 | $1000K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (2)
- F1. On January 29, 2026, Cibus, Inc. (the "Issuer") entered into an Underwriting Agreement (the "Underwriting Agreement") in connection with a firm commitment underwritten public offering (the "Offering"), which closed on January 30, 2026. The reporting person purchased 666,666 shares of Class A Common Stock in the Offering at the public offering price of $1.50 per share. The transaction was approved by the Issuer's board of directors in accordance with Rule 16b-3.
- F2. Held by JPL Investments, SA, which the reporting person is deemed to beneficially own.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cibus (CBUS) disclose for Jean-Pierre Jules Lehmann?
Was the Cibus (CBUS) insider purchase part of a public offering?
AI-generated analysis. How Rhea-AI works. Not financial advice.